Prelude Therapeutics
PRLD
$3.85
Share price
-0.52%
Change (1 day)
-30.76%
Change (1 year)
Categories
Prelude Therapeutics (PRLD) - Net assets
Net assets on the balance sheet as of March 2024 : $0.21 B
According to Prelude Therapeutics's latest financial reports the company has $0.21 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Prelude Therapeutics - Net assets on balance sheet (from 2019 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.23 B | 21.31% |
| 2022-12-31 | $0.19 B | -31.64% |
| 2021-12-31 | $0.28 B | 34.74% |
| 2020-12-31 | $0.21 B | -529.42% |
| 2019-12-31 | $-49.42 M | 117.74% |
| 2018-12-31 | $-22.7 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.32 B | 55.95% | 🇺🇸 USA |